Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases
Methodological detailsmultidisciplinary steering committee, systematic literature searches, consensus finding and voting process
- Multidisciplinary steering committee
- Systematic literature searches
- Consensus finding and voting process
Recommendations
As issued by the authors
Overarching principle: higher risk of major CV events (MACE) and venous thromboembolism (VTE) in chronic inflammatory rheumatic diseases vs the general population.
Overarching principle: the rheumatologist has a central role in evaluating cardiovascular disease (CVD) and VTE risk in these patients.
Overarching principle: MACE and VTE risk should be regularly assessed, particularly before initiating targeted therapies.
Original publication
Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases. Joint Bone Spine. Published 16 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →